Across its top 20 institutional holders, NNVC's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 10/100, avg. turnover score 31/100).

Quarterly Activity

Recent Activity

+$734.9K

Total Buy Value

$2.0M

Total Sell Value

New buy11

Trim4

Add9

Sold out7

Net Buyers

Net Sellers

Smart Money Convergence

NNVC does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/NNVC

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-17

2026-07-17

NanoViricides entered into an at-the-market sales agreement with D. Boral Capital LLC on July 17, 2026. The company can sell its common stock through the sales agent on a continuous basis, paying a 2.0% commission on gross proceeds. A prospectus supplement was filed under the existing shelf registration.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

630087302

FAQ

Who are the top institutional investors holding NANOVIRICIDES INC (NNVC)?

Major stakeholders currently include Vanguard Capital Management LLC ($466.5K), Geode Capital Management, LLC ($205.6K), UBS Group AG ($194.6K). Based on the latest 13F filings, there are a total of 49 tracked investment funds and institutions maintaining positions in NNVC.

What is the overall institutional sentiment toward NNVC recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $465.1K, driven by 20 managers accumulating shares while 11 reduced their exposure.

Which institutions have been selling or reducing their NNVC positions?

In the latest period, 4 funds trimmed their holdings, and 7 managers completely exited their positions. The aggregate reported sell value was $2.0M.

Are there any notable investors adding NNVC to their portfolios?

Yes, buying activity remains notable. 11 institutions opened new positions in {ticker}, and 9 existing holders added to their shares. The total reported buy value for the quarter amounted to $734.9K.